PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-90.13%
Revenue decline while Healthcare median is 0.00%. Seth Klarman would investigate if market share loss is temporary.
No Data
No Data available this quarter, please select a different quarter.
-148.93%
Gross profit decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-595.65%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
15.04%
R&D change of 15.04% versus flat Healthcare spending. Walter Schloss would verify adequacy.
33.15%
G&A change of 33.15% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.43%
Operating expenses growth exceeding 1.5x Healthcare median of 7.77%. Jim Chanos would check for waste.
20.43%
Total costs growth exceeding 1.5x Healthcare median of 7.89%. Jim Chanos would check for waste.
No Data
No Data available this quarter, please select a different quarter.
3.01%
D&A growth exceeding 1.5x Healthcare median of 1.34%. Jim Chanos would check for overinvestment.
-24.86%
EBITDA decline while Healthcare median is -3.70%. Seth Klarman would investigate causes.
-1164.87%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-24.41%
Operating income decline while Healthcare median is -6.51%. Seth Klarman would investigate causes.
-1160.31%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-17.39%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-24.71%
Pre-tax income decline while Healthcare median is -6.80%. Seth Klarman would investigate causes.
-1163.35%
Pre-tax margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-24.71%
Net income decline while Healthcare median is -6.36%. Seth Klarman would investigate causes.
-1163.35%
Net margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-23.33%
EPS decline while Healthcare median is -2.36%. Seth Klarman would investigate causes.
-23.33%
Diluted EPS decline while Healthcare median is -1.75%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.